GSK3B and epilepsy: In addition, treatment with lithium or GSK3β inhibitors suppress GSK3β activity and thus corrects behavioral phenotypes in animal models of NDDs, including ID, ASD, SZ, and epilepsy (Fuchs et al., 2015; Guo et al., 2012; Mao et al., 2009).